| [1] |
中华医学会结核病学分会, 抗结核药物超说明书用法专家共识编写组. 抗结核药物超说明书用法专家共识. 中华结核和呼吸杂志, 2018, 41(6):447-460. doi: 10.3760/cma.j.issn.1001-0939.2018.06.006.
doi: 10.3760/cma.j.issn.1001-0939.2018.06.006
|
| [2] |
张燕. 莫西沙星在临床使用中的不良反应及安全用药探讨. 国际医药卫生导报, 2020, 26(3):379-381. doi: 10.3760/cma.j.issn.1007-1245.2020.03.026.
doi: 10.3760/cma.j.issn.1007-1245.2020.03.026
|
| [3] |
罗敏, 唐尧. 静脉滴注莫西沙星及甲硝唑致剥脱性皮炎的药学分析. 中国药物警戒, 2011, 8(7):447-448. doi: 10.3969/j.issn.1672-8629.2011.07.022.
doi: 10.3969/j.issn.1672-8629.2011.07.022
|
| [4] |
李莉, 王东晓, 朱曼. 1例药源性大疱性皮肤不良反应分析. 中国医院药学杂志, 2014, 34(5):420-421. doi: 10.13286/j.cnki.chinhosppharmacyj.2014.05.25.
doi: 10.13286/j.cnki.chinhosppharmacyj.2014.05.25
|
| [5] |
Prins JM, Koopmans RP. Novel side effects of moxifloxacin: making a balanced decision again. Ned Tijdschr Geneeskd, 2008, 152(34):1862-1864.
pmid: 18788675
|
| [6] |
Weaver CH, Huddleston HM, Kingsley MM, et al. Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis. J Drugs Dermatol, 2009, 8(11):1031-1033.
pmid: 19894372
|
| [7] |
贾王平, 郭代红, 寇炜, 等. 我院6365例莫西沙星用药患者中皮肤变态反应的自动监测研究. 中南药学, 2017, 15(11):1505-1508. doi: 10.7539/j.issn.1672-2981.2017.11.001.
doi: 10.7539/j.issn.1672-2981.2017.11.001
|
| [8] |
Nori S, Nebesio C, Brashear R, et al. Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure. Arch Dermatol, 2004, 140(12):1537-1538. doi: 10.1001/archderm.140.12.1537.
doi: 10.1001/archderm.140.12.1537
|
| [9] |
Howard-Thompson A, Cartmell B, Suda KJ. Toxic epidermal necrolysis reaction associated with the use ofmoxifloxacin. Int J Antimicrob Agents, 2014, 44(2):178-179. doi: 10.1016/j.ijantimicag.2014.04.002.
doi: 10.1016/j.ijantimicag.2014.04.002
URL
|
| [10] |
王平, 谢婷, 范瑞强, 等. 急性泛发性发疹性脓疱病1例. 临床皮肤科杂志, 2020, 49(9):549-551. doi: 10.16761/j.cnki.1000-4963.2020.09.012.
doi: 10.16761/j.cnki.1000-4963.2020.09.012
|
| [11] |
郎桂荣, 李薇, 郭在培. 急性泛发性发疹性脓疱病. 华西医学, 2005, 20(1):203. doi: 10.3969/j.issn.1002-0179.2005.01.150.
doi: 10.3969/j.issn.1002-0179.2005.01.150
|
| [12] |
中华医学会结核病学分会结核性脑膜炎专业委员会. 2019中国中枢神经系统结核病诊疗指南. 中华传染病杂志, 2020, 38(7):400-408. doi: 10.3760/cma.j.cn311365-202006-00645.
doi: 10.3760/cma.j.cn311365-202006-00645
|
| [13] |
吴术其. 抗结核药物联合莫西沙星治疗结核性脑膜炎的临床疗效. 临床合理用药杂志, 2019, 12(15):48-49. doi: 10.15887/j.cnki.13-1389/r.2019.15.022.
doi: 10.15887/j.cnki.13-1389/r.2019.15.022
|
| [14] |
唐彪, 柯国琳, 吴辰, 等. 急性泛发性发疹性脓疱病60例临床分析. 湘南学院学报(医学版), 2021, 23(1):52-54. doi: 10.16500/j.cnki.1673-498x.2021.01.015.
doi: 10.16500/j.cnki.1673-498x.2021.01.015
|
| [15] |
李博, 高蕊, 李睿, 等. 药物临床试验不良反应/不良事件关联性判定方法研究探讨. 中国新药杂志, 2014, 23(12):1465-1470.
|
京公安网备11010202008787号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可
